Clinical Trial Update: Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

Phase 1 trial of a vaccine therapy for patients undergoing surgery for recurrent glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: John Sampson | Conditions: Recurrent Central Nervous System Neoplasm | Phase 1 | Status: COMPLETED